Your browser doesn't support javascript.
loading
Heterogeneity in Characteristics and Outcomes of Patients who met the Indications for Vericiguat Approved by the Japanese Agency: From the KCHF Registry.
Shiba, Masayuki; Kato, Takao; Morimoto, Takeshi; Yaku, Hidenori; Inuzuka, Yasutaka; Tamaki, Yodo; Ozasa, Neiko; Seko, Yuta; Yamamoto, Erika; Yoshikawa, Yusuke; Kitai, Takeshi; Yamashita, Yugo; Iguchi, Moritake; Nagao, Kazuya; Kawase, Yuichi; Morinaga, Takashi; Toyofuku, Mamoru; Furukawa, Yutaka; Ando, Kenji; Kadota, Kazushige; Sato, Yukihito; Kuwahara, Koichiro; Kimura, Takeshi.
Affiliation
  • Shiba M; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kato T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: tkato75@kuhp.kyoto-u.ac.jp.
  • Morimoto T; Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Yaku H; Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.
  • Inuzuka Y; Cardiovascular Medicine, Shiga General Hospital, Moriyama, Japan.
  • Tamaki Y; Division of Cardiology, Tenri Hospital, Tenri, Japan.
  • Ozasa N; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Seko Y; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Yamamoto E; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Yoshikawa Y; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kitai T; Division of Heart Failure, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Yamashita Y; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Iguchi M; Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Nagao K; Department of Cardiology, Osaka Red Cross Hospital, Osaka, Japan.
  • Kawase Y; Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Morinaga T; Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan.
  • Toyofuku M; Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
  • Furukawa Y; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Ando K; Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan.
  • Kadota K; Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Sato Y; Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
  • Kuwahara K; Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine, Nagano, Japan.
  • Kimura T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
J Card Fail ; 29(6): 976-978, 2023 06.
Article in En | MEDLINE | ID: mdl-37059291
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Heart Failure / Heterocyclic Compounds, 2-Ring Limits: Humans Language: En Journal: J Card Fail Journal subject: CARDIOLOGIA Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Heart Failure / Heterocyclic Compounds, 2-Ring Limits: Humans Language: En Journal: J Card Fail Journal subject: CARDIOLOGIA Year: 2023 Type: Article Affiliation country: Japan